With more than $3.7 million in funding from the National Institute on Aging, Medical University of South Carolina neuropsychologist Andreana Benitez, Ph.D., of the Department of Neurology in the College of Medicine will lead a phase II clinical trial to determine the optimal dose of transcranial magnetic stimulation, or TMS, needed to improve symptoms for patients with depression and mild cognitive impairment, or MCI.
Dementia risk rises with elevated remnant cholesterol, South Korean study reveals
How remnant cholesterol (remnant-C) levels are associated with the risk of developing dementia using a large dataset from South Korea.
July 30, 2024